SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on October 18, 2011, reporting events that occurred on October 13, 2011. The filing covers the Company's Annual Meeting of Stockholders, changes to the Board of Directors, and amendments to the Company's Bylaws. Note: The input metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Corporate Actions
- Board of Directors Changes: Richard S. Schneider, Ph.D., retired from the Board. Gary T. Steele resigned as a Class 2 director and was immediately re-elected as a Class 1 director.
- Bylaw Amendment: The Board approved an amendment to decrease the number of authorized directors from nine (9) to eight (8).
- Annual Meeting Results:
- Director Elections: All five Class 2 director nominees were elected.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP for the fiscal year ending May 27, 2012.
- Executive Compensation: Stockholders approved the non-binding advisory proposal on executive compensation.
- Compensation Vote Frequency: Stockholders voted to hold the advisory vote on executive compensation annually.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors. The primary operational update is the Board's determination to conduct annual advisory votes on executive compensation based on stockholder preference.
Key Facts for Investor Verification
- Verify the reduction of the Board size from 9 to 8 directors and the specific composition of the new Board.
- Confirm the re-election of Gary T. Steele as a Class 1 director following his resignation as a Class 2 director.
- Note the stockholder preference for annual executive compensation advisory votes.
- Review the Amended and Restated Bylaws (Exhibit 3.1) for details on the governance changes.